Search company, investor...

Founded Year



Series B | Alive

Total Raised


Last Raised

$78M | 2 yrs ago

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

+30 points in the past 30 days

About Exo Therapeutics

Exo Therapeutics is a company focused on the medical sector, specifically in the domain of drug development. The company's main service is the development of drugs that modulate enzyme activity, with a particular focus on oncology and inflammation. These drugs are designed to unlock intractable drug targets with precision and potency. It was founded in 2018 and is based in Watertown, Massachusetts.

Headquarters Location

480 Arsenal Way

Watertown, Massachusetts, 02472,

United States



Research containing Exo Therapeutics

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Exo Therapeutics in 1 CB Insights research brief, most recently on Jan 19, 2021.

Latest Exo Therapeutics News

Exo Therapeutics Frequently Asked Questions (FAQ)

  • When was Exo Therapeutics founded?

    Exo Therapeutics was founded in 2018.

  • Where is Exo Therapeutics's headquarters?

    Exo Therapeutics's headquarters is located at 480 Arsenal Way, Watertown.

  • What is Exo Therapeutics's latest funding round?

    Exo Therapeutics's latest funding round is Series B.

  • How much did Exo Therapeutics raise?

    Exo Therapeutics raised a total of $103M.

  • Who are the investors of Exo Therapeutics?

    Investors of Exo Therapeutics include Novartis Venture Funds, CRV, 6 Dimensions Capital, Newpath Partners, BVF Partners and 6 more.



CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.